![Samantha Truex](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Samantha Truex
Directeur/Membre du Conseil chez
AVALO THERAPEUTICS, INC.
Fortune : 115 577 $ au 31/07/2026
Profil
Samantha Truex is currently Chief Executive Officer at Oblenio Bio, Inc. since 2025, Chairman at Artios Pharma Ltd. since 2022, and Independent Director at Avalo Therapeutics, Inc. since 2024.
Former roles include Chief Executive Officer at Quench Bio, Inc. and Upstream Bio, Inc., Director at Sanofi from 1998 to 2006, Director at HotSpot Therapeutics, Inc., Vice President-Corporate Development at Biogen, Inc. from 2010 to 2014, Adviser at Atlas Venture Advisors, Inc., Chief Business Officer at Padlock Therapeutics, Inc., and Chief Operating Officer at Synlogic Therapeutics from 2016 to 2017.
Education includes an undergraduate degree from Dartmouth College in 1992, an undergraduate degree from Thayer School of Engineering at Dartmouth in 1993, and an MBA from Tuck School of Business at Dartmouth in 1995.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
AVALO THERAPEUTICS INC 0,01 % | 02/06/2026 | 6 333 ( 0,01 % ) | 115 577 $ | 31/07/2026 |
Postes actifs de Samantha Truex
| Sociétés | Poste | Début |
|---|---|---|
| AVALO THERAPEUTICS, INC. | Directeur/Membre du Conseil | 28/03/2024 |
Artios Pharma Ltd.
 Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for cancer treatment | Président | 01/06/2022 |
Anciens postes connus de Samantha Truex
| Sociétés | Poste | Fin |
|---|---|---|
Synlogic Therapeutics
 Synlogic Therapeutics Pharmaceuticals: OtherHealth Technology Develops medicine for patients | Directeur des opérations | 30/06/2017 |
| BIOGEN INC. | Directeur/Membre du Conseil | 01/04/2010 |
| SANOFI | Directeur/Membre du Conseil | 31/12/2006 |
| UPSTREAM BIO, INC. | Directeur Général | - |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Consultant / Advisor | - |
Formation de Samantha Truex
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
96
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Finance |
Tuck School of Business at Dartmouth
 Tuck School of Business at Dartmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avalo Therapeutics, Inc.
 Avalo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for patients with unmet clinical need in immunology and rare genetic diseases | Health Technology |
Thayer School of Engineering At Dartmouth
 Thayer School of Engineering At Dartmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Padlock Therapeutics, Inc.
 Padlock Therapeutics, Inc. BiotechnologyHealth Technology Develops medicines targeting protein-arginine deiminases | Health Technology |
Artios Pharma Ltd.
Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for cancer treatment | Health Technology |
HotSpot Therapeutics, Inc.
 HotSpot Therapeutics, Inc. BiotechnologyHealth Technology Develops allosteric therapies | Health Technology |
Quench Bio, Inc.
 Quench Bio, Inc. BiotechnologyHealth Technology Develops therapies targeting innate immune pathways to treat life-threatening auto-immune and inflammatory diseases | Health Technology |
Synlogic Therapeutics
Synlogic Therapeutics Pharmaceuticals: OtherHealth Technology Develops medicine for patients | Health Technology |
Upstream Bio, Inc.
 Upstream Bio, Inc. BiotechnologyHealth Technology Engages in developing treatments for inflammatory diseases | Health Technology |
